The impact of antiepileptic polytherapy on mood and cognitive function

Acta Neurologica Belgica

Volumn 111, Issue 1, 2011, Pages 29-32

  Rösche, Johannes ^a,c   Kundt, Günther ^c   Weber, Raimund ^a,b   Fröscher, Walter ^a   Uhlmann, Carmen ^a  

^a Epilepsiezentrum Bodensee ^*  (Germany)

^b BDH Klinik Vallendar GmbH   (Germany)

^c UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Cognition; Depression; Intelligence; Polytherapy

Indexed keywords

ANTICONVULSIVE AGENT;

ADULT; ANTICONVULSANT THERAPY; ARTICLE; COGNITION; COGNITIVE DEFECT; DEPRESSION; DISEASE DURATION; DRUG EFFECT; EPILEPSY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD; NEUROPSYCHOLOGICAL TEST; RETROSPECTIVE STUDY; RISK FACTOR; ANALYSIS OF VARIANCE; CHEMICALLY INDUCED DISORDER; DRUG COMBINATION; MIDDLE AGED; MOOD DISORDER; PREDICTIVE VALUE; PSYCHOMETRY;

ADULT; ANALYSIS OF VARIANCE; ANTICONVULSANTS; COGNITION DISORDERS; DRUG THERAPY, COMBINATION; EPILEPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; MOOD DISORDERS; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; PSYCHOMETRICS;

EID: 79955835592     PISSN: 03009009     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Aldenkamp AP. Antiepileptic drug treatment and epileptic seizures-effects on cognitive function. In: Trimble M, Schmitz B, eds. The Neuropsychiatry of Epilepsy. Cambridge, Cambridge university Press; 2002: pp. 256-265.
2. Vermeulen J, Aldenkamp AP. Cognitive side-effects of chronic antiepileptic drug treatment: A review of 25 years of research. Epilepsy Res. 1995; 22: 65-95.
3. Lehrl S. Mehrfachwahl-Wortschatz-Intelligenztest: MWT-A. Erlangen, Perimed; 1991.
4. Lehrl S, Gallwitz A, Blaha L, Fischer B. Kurztest für allgemeine Intelligenz (KAI). 3rd ed. Ebersberg, Vless; 1992.
5. Schaaf S, Kessler J, Grond M, Fink GR. Memo-Test. Weinheim, Beltz; 1992.
6. Benton Sivan AL, Spreen O. The revised visual retention test [German ed Der Benton-Test]. Bern, Huber; 1995.
7. Lehrl S, Fischer B. C.I.-Test zur Frühdiagnostik von Demenzen. 4th ed. Ebersberg, Vless; 1992.
8. Zung WWK. A self-rating depression scale. Arch Gen Psych. 1965; 13: 508-515.
9. Rösche J, Uhlmann C, Weber R. Der Einfluss von Erkrankungsalter, Lebensalter und Krankheitsdauer auf die kognitiven Leistungen bei Patienten mit therapierefraktärer Epilepsie. Fortschr Neurol Psychiat. 2003; 71: 595-599.
10. Mula M, Trimble MR. Antiepileptic drug-induced cognitive adverse effects: potential mechanisms and contributing factors. CNS Drugs. 2009; 23: 121-137.
11. Canevini MP, De Sarro G, Galimberti CA, Gatti G, Licchetta L. et al. Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy. Epilepsia. 2010; 51: 797-804.